CYTK Q1 2022 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-82.5% YoY

Gross Profit

-$45M-3901.3% margin

Operating Income

-$78M-6782.0% margin

Net Income

-$89M-7791.4% margin

EPS (Diluted)

$-1.19

QoQ Revenue Growth

-97.9%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$28M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$856M

Total Liabilities

$740M

Stockholders' Equity

$116M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$7M	-82.5%
Gross Profit	-$45M	-$25M	-79.1%
Operating Income	-$78M	-$41M	-91.7%
Net Income	-$89M	-$47M	-89.9%

Revenue Segments

Research And Development

$1M100%